Sclerosis News and Research

RSS

23% of dementia cases linked to controllable risk factors vary by race and ethnicity

Approximately 23% of people diagnosed with Alzheimer's disease or another related dementia in their 60s and later have cases that can be explained by controllable risk factors such as high blood pressure, diabetes, physical inactivity, and too little or too much sleep, and that percentage varies depending on race and ethnicity, according to a new study published in the January 17, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

17 Jan 2024

Migraine disability worsens with stigma, study reveals

Migraine can impact many aspects of a person's life, but less is known about how feelings of stigma about the disease affect quality of life. For people with migraine, these feelings of stigma were linked to more disability, increased disease burden and reduced quality of life, according to new research published in the January 17, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

17 Jan 2024

America’s health system isn’t ready for the surge of seniors with disabilities

The number of older adults with disabilities — difficulty with walking, seeing, hearing, memory, cognition, or performing daily tasks such as bathing or using the bathroom — will soar in the decades ahead, as baby boomers enter their 70s, 80s, and 90s.

17 Jan 2024

Ancient genomes reveal origins of multiple sclerosis risk in Europe

Researchers investigated the variables contributing to geographical heterogeneity in multiple sclerosis prevalence and the impact of genetic and environmental factors on the disease's development.

15 Jan 2024

Ancient DNA traces multiple sclerosis origins to 5,000-year-old migrations

Researchers create the world's largest ancient human gene bank, linking genes to multiple sclerosis risk and tracing its origins to migrations 5,000 years ago.

13 Jan 2024

Research reveals the function of a little-understood junction between brain cells

New research from Oregon Health & Science University for the first time reveals the function of a little-understood junction between cells in the brain that could have important treatment implications for conditions ranging from multiple sclerosis to Alzheimer's disease, to a type of brain cancer known as glioma.

12 Jan 2024

Association between vitamin D supplementation and fatigue

The mechanisms underlying vitamin D’s effects on fatigue.

12 Jan 2024

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

In our latest interview, News-Medical speaks with Rosanna Zhang from ACROBiosystems about utilizing organoids for disease modeling in the field of neuroscience research.

From Aneuro - An ACROBiosystems Brand 11 Jan 2024

Blocking brain inflammation could slow, reverse ALS symptoms

In people with amyotrophic lateral sclerosis (ALS), changes in neurons appear to activate immune cells. Lowering the inflammation could reduce the symptoms of the disease, according to a study led by Chantelle Sephton, a professor at Université Laval's Faculty of Medicine.

10 Jan 2024

Widespread pain makes exercise a challenge for some patients with multiple sclerosis

For patients with multiple sclerosis, a regular exercise routine is important for managing symptoms. Due to different causes of chronic pain though, physical exercise can be more difficult for some.

10 Jan 2024

Using machine learning to predict disease progression in multiple sclerosis

A combination of only 11 proteins can predict long-term disability outcomes in multiple sclerosis (MS) for different individuals.

9 Jan 2024

Infammasomes provide a therapeutic target against human diseases

The structure of inflammasomes and their role in diseases.

9 Jan 2024

Study reveals bidirectional association between autoimmune disease and perinatal depression

Women with autoimmune disease are more likely to suffer from depression during pregnancy and after childbirth; conversely, women with a history of perinatal depression are at higher risk of developing autoimmune disease, a new study from Karolinska Institutet published in the journal Molecular Psychiatry reports.

8 Jan 2024

Study finds Epstein-Barr virus T-cells prevalent in early multiple sclerosis

A study led by UTHealth Houston reveals that T-cells specific for Epstein-Barr virus-infected cells are highly present in the cerebrospinal fluid of people with early-stage multiple sclerosis, suggesting a link between EBV and the disease.

8 Jan 2024

Gut microbiota: the new frontier in Alzheimer’s disease research and therapy

The current evidence of the role of gut microbiota in Alzheimer’s disease (AD) pathogenesis.

8 Jan 2024

Speech Accessibility Project expands to include ALS patients in U.S. and Puerto Rico

The Speech Accessibility Project has expanded its recruitment and is inviting U.S. and Puerto Rican adults living with amyotrophic lateral sclerosis to participate.

5 Jan 2024

New approach leverages macrophages to treat traumatic brain injury

Scientists have created a new treatment for traumatic brain injury (TBI) that shrank brain lesions by 56% and significantly reduced local inflammation levels in pigs.

3 Jan 2024

Radon exposure linked to increased risk of blood cell mutation in female stroke patients

Radon, a naturally occurring radioactive gas produced when metals like uranium or radium break down in rocks and soil, is a known cause of lung cancer.

3 Jan 2024

Fragmented sleep in midlife linked to poorer cognitive function a decade later

People who have more disrupted sleep in their 30s and 40s may be more likely to have memory and thinking problems a decade later, according to new research published in the January 3, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

3 Jan 2024

Natural compounds show promise in modulating heme breakdown, offering new therapeutic avenues

Study explores the impact of natural compounds on bilirubin production and heme catabolic pathway modulation, highlighting their potential in treating neurodegenerative and cardiovascular diseases.

3 Jan 2024

Sclerosis News and Research

23% of dementia cases linked to controllable risk factors vary by race and ethnicity

Migraine disability worsens with stigma, study reveals

America’s health system isn’t ready for the surge of seniors with disabilities

Ancient genomes reveal origins of multiple sclerosis risk in Europe

Ancient DNA traces multiple sclerosis origins to 5,000-year-old migrations

Research reveals the function of a little-understood junction between brain cells

Association between vitamin D supplementation and fatigue

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Blocking brain inflammation could slow, reverse ALS symptoms

Widespread pain makes exercise a challenge for some patients with multiple sclerosis

Using machine learning to predict disease progression in multiple sclerosis

Infammasomes provide a therapeutic target against human diseases

Study reveals bidirectional association between autoimmune disease and perinatal depression

Study finds Epstein-Barr virus T-cells prevalent in early multiple sclerosis

Gut microbiota: the new frontier in Alzheimer’s disease research and therapy

Speech Accessibility Project expands to include ALS patients in U.S. and Puerto Rico

New approach leverages macrophages to treat traumatic brain injury

Radon exposure linked to increased risk of blood cell mutation in female stroke patients

Fragmented sleep in midlife linked to poorer cognitive function a decade later

Natural compounds show promise in modulating heme breakdown, offering new therapeutic avenues

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News